Physician profile
Robert Parnes
NPI 1568454825
$2,366.28
in general payments reported to CMS, 2019-2025
16 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $92.72 · 2021: $216 · 2022: $360 · 2023: $554 · 2024: $439 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $285.70 | 2019-2024 | Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $268.77 | 2019-2023 | Cequa |
| Horizon Therapeutics Plc | $246.27 | 2022-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $236.75 | 2025 | Xiidra, Miebo, Scoutpro Osmolarity System |
| Maculogix, INC. | $141.11 | 2019 | |
| Sight Sciences, INC. | $140.25 | 2023 | Omni Surgical System |
| Johnson & Johnson Vision Care, INC. | $126.68 | 2023 | Acuvue |
| Ocular Therapeutix, INC. | $125.98 | 2024 | Dextenza |
| Harrow Eye, LLC | $125.00 | 2025 | Vevye |
| Amgen INC. | $121.85 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $109.28 | 2024 | Tecnis Iol |
| Abbvie INC. | $107.95 | 2022 | |
| Eyevance Pharmaceuticals LLC | $93.48 | 2021 | |
| Lombart Brothers, INC. | $92.72 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $80.58 | 2025 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Samsara Vision | $63.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.